Cyteir Therapeutics
Why Robinhood?
You can watch CYTT and buy or sell other stocks, ETFs, and their options commission-free!About CYTT
Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies.
CYTT Key Statistics
Stock Snapshot
With a market cap of 108.35M, Cyteir Therapeutics(CYTT) trades at $3.01. The stock has a price-to-earnings ratio of -3.23.
On 2026-03-10, Cyteir Therapeutics(CYTT) stock opened at —, reached a high of —, and a low of —.
The Cyteir Therapeutics(CYTT)'s current trading volume is 0, compared to an average daily volume of 645.29K.
In the last year, Cyteir Therapeutics(CYTT) shares hit a 52-week high of $3.19 and a 52-week low of $1.65.
In the last year, Cyteir Therapeutics(CYTT) shares hit a 52-week high of $3.19 and a 52-week low of $1.65.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.